FDA breast implants workshop
This article was originally published in The Gray Sheet
Executive Summary
Meeting to "provide a forum for the FDA to present draft guidance concerning testing requirements for alternative breast prostheses" is scheduled for Oct. 21 in Washington, D.C., FDA says. The meeting will also include "discussion and information exchange" by FDA and invited scientific experts. Participation from the public "will be limited to written questions" facilitated by a moderator, the agency notes. To register, call 301/608-3542